Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT7519M Alone and in Combination With Bortezomib in Multiple Myeloma
NCT01183949Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Nov 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AT-7519 in multiple myeloma (MM), sponsored by Astex Pharmaceuticals. Started Nov 2010; status: completed.
02
Drugs
AT-7519
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01183949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01183949.